CDC Guidelines for Tetanus Prophylaxis in Wound Management

Wound Classification

Clean, minor wounds are defined as small, superficial injuries with minimal tissue damage, less than 6 hours old and not contaminated. 1
Contaminated or high‑risk wounds include injuries contaminated with dirt, feces, soil, saliva, puncture wounds, avulsions, missile injuries, crushing injuries, burns, frostbite, or any wound with significant tissue damage. 2

Timing of Booster Based on Wound Type

For clean, minor wounds, a tetanus booster is required only if the last tetanus-containing vaccine was administered ≥10 years ago; otherwise no booster is needed. 2
For contaminated/high‑risk wounds, a booster is required only if the last tetanus‑containing vaccine was administered ≥5 years ago; otherwise no booster is needed. 2

Decision Algorithm by Vaccination History

Patients with Completed Primary Series (≥ 3 doses)

Clean, minor wounds – no tetanus vaccine needed if the last dose was <10 years ago; give a booster if ≥10 years ago. TIG is never required. 2
Contaminated/high‑risk wounds – no tetanus vaccine needed if the last dose was <5 years ago; give a booster if ≥5 years ago. TIG is not required. 2

Patients with Unknown or Incomplete Primary Series (< 3 doses)

All wound types – administer a tetanus vaccine immediately. 2
Contaminated/high‑risk wounds – give tetanus immune globulin (TIG) 250 U intramuscularly in addition to the vaccine. 1, 3, 2
Clean, minor wounds – TIG is not required. 2
Administration technique – give TIG and vaccine at separate anatomical sites using separate syringes. 1, 3, 2

Vaccine Selection by Age and Pregnancy

Individuals ≥ 11 years who have never received Tdap or whose Tdap history is unknown should receive Tdap (preferred). 2, 4
Non‑pregnant persons ≥ 11 years with documented prior Tdap should receive Td. 2, 4
Pregnant patients should receive Tdap regardless of prior Tdap status. 2, 4
When Td is unavailable, Tdap may be used as a substitute. 2, 4

Pediatric Vaccine Selection

Children < 7 years – use DTaP. 1, 3, 2
Children 7–10 years – use Td. 1, 3, 2
Children ≥ 11 years – use Tdap. 1, 3, 2

Special Populations

History of Arthus‑type hypersensitivity – do not administer tetanus vaccine more frequently than every 10 years, even for contaminated wounds. 5
Immunocompromised patients (e.g., HIV‑infected or severely immunodeficient) with contaminated wounds should receive TIG regardless of prior vaccination. 2
Patients unable to provide vaccination history – treat as unvaccinated: give tetanus vaccine and, for contaminated wounds, TIG. 1, 3, 2
Mass‑casualty situations with limited TIG – prioritize TIG for patients > 60 years and immigrants from regions outside North America/Europe. 1, 3

Booster Frequency and Safety

Administering boosters more frequently than recommended increases the risk of Arthus reactions without providing additional protection. 5
Individuals vaccinated within 5 years for contaminated wounds or 10 years for clean wounds are already protected and do not require an additional booster. 2

Primary Series Verification and Completion

Verification of completion of the 3‑dose primary tetanus series is essential; if verification is not possible, the patient should be assumed unvaccinated. 2, 1, 3
Patients receiving tetanus vaccine for wound management who lack a complete primary series must complete the full 3‑dose series: first dose at the time of wound care, second dose ≈ 2 months later, and third dose 6–8 months after the second dose. 1, 3, 2

Tetanus Prophylaxis Guidelines for Wound Management Based on Vaccination History

Decision Algorithm (Wound Type & Vaccination Timing)

For patients who received any tetanus‑containing vaccine within the past 10 years, no tetanus booster is required for clean, minor wounds; a booster is indicated for contaminated or high‑risk wounds only when ≥5 years have elapsed since the last dose. [CDC 6]
The need for tetanus prophylaxis is determined by (1) wound classification (clean minor vs. contaminated/high‑risk) and (2) time since the most recent tetanus‑containing vaccination. [CDC 7]
Clean, minor wounds: if the patient has completed the primary 3‑dose series and received any tetanus‑containing vaccine within the past 10 years, no tetanus vaccine is required. [CDC 8]
Clean, minor wounds: tetanus immune globulin (TIG) is not needed regardless of vaccination timing. [CDC 9]
Contaminated or high‑risk wounds (e.g., dirt, feces, soil, saliva contamination; puncture, avulsion, missile, crushing injuries, burns, frostbite) require a booster if ≥5 years have passed since the last tetanus‑containing dose; no booster is needed if <5 years have passed. [CDC 8][10]
For contaminated/high‑risk wounds, TIG is not required when the patient has completed the primary 3‑dose series, irrespective of the interval since the last dose. [CDC 9]

Vaccine Selection for Patients ≥ 11 Years Needing a Booster

Tdap is the preferred booster for individuals who have never received Tdap or whose Tdap history is unknown. [CDC 11]
Td should be used for non‑pregnant persons with documented prior Tdap vaccination. [CDC 10]
Tdap is recommended for pregnant patients, regardless of prior Tdap status. [CDC 8]
When Td is unavailable, Tdap may be used as a substitute. [CDC 7]

Timing Intervals for Routine and Wound‑Related Boosters

5‑year rule (wound‑related): individuals vaccinated less than 5 years ago are considered protected and do not require additional tetanus vaccine or TIG for wound management. [CDC 12]
10‑year rule (routine immunization): tetanus boosters are recommended every 10 years for routine (non‑wound) protection. [CDC 13]

Special Populations

History of Arthus‑type Hypersensitivity

Patients with a prior Arthus‑type reaction to tetanus vaccine should delay any further tetanus vaccination for >10 years after the most recent dose, regardless of wound severity. [CDC 11]
This >10‑year interval also applies to contaminated or severe wounds in these patients. [CDC 11]
TIG decisions for these patients remain based on primary series completion, not on the hypersensitivity history. [CDC 9]

Immunocompromised Individuals

HIV‑infected or severely immunodeficient patients with contaminated wounds should receive TIG regardless of prior tetanus immunization. [CDC 8]

Safety Considerations & Common Pitfalls

Avoid unnecessary boosters: administering tetanus vaccine more frequently than recommended increases the risk of adverse reactions, including Arthus reactions; patients vaccinated within the past 5 years are already protected and gain no additional benefit from repeat dosing. [CDC 12]
Primary series verification: clinicians should always ascertain completion of the 3‑dose primary tetanus series. When vaccination history is unknown or uncertain, the patient should be treated as unvaccinated, receiving both tetanus vaccine and TIG as indicated. [CDC 7]
Separate administration sites: when both TIG and tetanus vaccine are indicated, they must be given using separate syringes at different anatomical sites. [CDC 12]

Tetanus Prophylaxis Guidelines for Spider Bites

Wound Classification & Timing of Booster

The CDC recommends a tetanus booster only for spider‑bite wounds that are contaminated or high‑risk (e.g., puncture wounds, dirt‑contaminated, or with significant tissue damage) when the patient’s last tetanus‑containing vaccine was ≥ 5 years ago; for clean, minor bites the booster is needed only if the last dose was ≥ 10 years ago. 14
Because the majority of spider bites are puncture wounds, they are generally classified as contaminated/high‑risk and therefore follow the 5‑year rule rather than the 10‑year rule. [14][15]

Vaccination Decision Based on Immunization History

Patients with a Completed Primary Series (≥ 3 doses)

Clean, minor bites – no tetanus vaccine is required if the last dose was < 10 years ago; give a booster if ≥ 10 years have elapsed. Tetanus immune globulin (TIG) is never indicated. 14
Contaminated/high‑risk bites – no tetanus vaccine is required if the last dose was < 5 years ago; give a booster if ≥ 5 years have elapsed. TIG is not required for these patients. [14][15]

Patients with Unknown or Incomplete Primary Series (< 3 doses)

All spider‑bite types – administer a tetanus vaccine immediately. 14
Contaminated/high‑risk bites – give TIG 250 U intramuscularly in addition to the vaccine, using separate syringes and anatomical sites. [14][15]
Clean, minor bites – TIG is not required. 14

Vaccine Selection for Booster (Patients ≥ 11 years)

Tdap is the preferred product for individuals who have never received Tdap or whose Tdap history is unknown. [14][16]
Td should be used for non‑pregnant persons with documented prior Tdap vaccination. [14][16]
Pregnant patients should receive Tdap regardless of prior Tdap status. [14][16]
When Td is unavailable, Tdap may be substituted. [14][16]

Critical Pitfalls & Special Considerations

Avoid over‑vaccination: Patients vaccinated within the past 5 years for contaminated wounds or within the past 10 years for clean wounds are already protected and do not require an additional booster. Over‑vaccination raises the risk of Arthus‑type hypersensitivity without added benefit. [17][14]
Verification of history: If a patient cannot provide documentation of completing the 3‑dose primary tetanus series, they should be managed as unvaccinated. [17][14]18
Immunocompromised hosts: HIV‑infected or severely immunodeficient patients with contaminated spider bites should receive TIG regardless of their prior tetanus immunization status. [14][15]
Prior Arthus‑type reaction: Individuals with a previous Arthus‑type hypersensitivity to tetanus vaccine should delay any tetanus toxoid‑containing vaccine until > 10 years after the most recent dose, even for contaminated wounds; TIG administration in these cases is based solely on primary‑series history. [14][18]15

Completing the Primary Series When Incomplete

Patients lacking a complete 3‑dose primary series should receive the first dose at the time of wound management, a second dose ≈ 4 weeks later, and a third dose 6–12 months after the second dose to achieve full protection. [17][14]16

Tetanus Prophylaxis for Contaminated or High‑Risk Wounds

Wound Classification

Prosthetic‑related injuries are considered contaminated or high‑risk wounds, which invoke the 5‑year tetanus booster rule rather than the 10‑year rule used for clean, minor wounds. 19

Vaccination Timing and Protection

An individual who has completed the primary tetanus series (≥ 3 doses) and received the most recent tetanus‑containing vaccine 3 years ago remains fully protected; a booster is required only when ≥ 5 years have elapsed since the last dose. 20
For contaminated/high‑risk wounds, the 5‑year interval is the evidence‑based threshold for recommending a tetanus booster. [19][20]

Tetanus Immune Globulin (TIG) Use

TIG is not indicated for any patient with a documented complete primary series, regardless of the time since the last vaccine dose. 20
TIG should be administered only to patients with an unknown or incomplete primary series (< 3 doses) who present with contaminated or high‑risk wounds. 20

Risks of Over‑Vaccination

Giving a tetanus booster to someone vaccinated < 5 years ago for a high‑risk wound provides no additional protection and markedly increases the risk of Arthus‑type hypersensitivity reactions. 19
The 2020 ACIP (Advisory Committee on Immunization Practices) guideline explicitly states that individuals vaccinated < 5 years prior to a high‑risk wound are already protected and should not receive a booster. 19

Documentation and Management of Uncertain Immunization History

If the completion of the 3‑dose primary series cannot be verified, the patient should be managed as unvaccinated, receiving both a tetanus vaccine (Tdap preferred if no prior Tdap, otherwise Td) and TIG for contaminated/high‑risk wounds. 20

Decision Algorithm for Contaminated/High‑Risk Wounds

< 5 years since last tetanus dose → No tetanus vaccine, no TIG required. 19
≥ 5 years since last tetanus dose → Administer a tetanus booster (Tdap preferred if no prior Tdap; Td if prior Tdap documented); TIG not required. [19][20]